Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2018 Dec;7(Suppl 4):S388-S392.
doi: 10.21037/tlcr.2018.08.12.

Elderly patients with stage III NSCLC survive longer when chemotherapy is added to radiotherapy-fortune favours the bold

Surein Arulananda  1   2   3 , Paul Mitchell  1   3   4
Affiliations
Editorial

Elderly patients with stage III NSCLC survive longer when chemotherapy is added to radiotherapy-fortune favours the bold

Surein Arulananda et al. Transl Lung Cancer Res. 2018 Dec.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Paul Mitchell declares Advisory Boards—AstraZeneca, Roche, Boehringer-Ingelheim, BMS, MSD, Celgene; Honoraria—Roche, Merck KGa; Travel Grants (conferences)—Roche, BMS, AstraZeneca. Dr. Surein Arulananda has no conflicts of interest to declare.

Comment on

Similar articles

See all similar articles

Cited by

References

    1. National Cancer Institute: SEER stat fact sheets: Lung and bronchus cancer. Available online: https://seer.cancer.gov/statfacts/html/lungb.html. Accessed 28 July 2018.
    1. Balducci L. Geriatric oncology: challenges for the new century. Eur J Cancer 2000;36:1741-54. 10.1016/S0959-8049(00)00169-6 - DOI - PubMed
    1. Miller ED, Fisher JL, Haglund KE, et al. The Addition of Chemotherapy to Radiation Therapy Improves Survival in Elderly Patients with Stage III Non-Small Cell Lung Cancer. J Thorac Oncol 2018;13:426-35. 10.1016/j.jtho.2017.11.135 - DOI - PMC - PubMed
    1. Schaake-Koning C, van den Bogaert W, Dalesio O, et al. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 1992;326:524-30. 10.1056/NEJM199202203260805 - DOI - PubMed
    1. Lee JS, Scott C, Komaki R, et al. Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: radiation therapy oncology group protocol 91-06. J Clin Oncol 1996;14:1055-64. 10.1200/JCO.1996.14.4.1055 - DOI - PubMed